GLS and benign prostatic hyperplasia: Thus, we first examined SCL1A5 and GLS1 levels in the tissue samples that did and did not progress to CRPC and found that the levels were significantly higher than that in BPH, whereas they were higher in the tissues that progressed to CRPC than in those that did not progress to CRPC (Fig. 4A).